Factors effective in the prevention of Preeclampsia:A systematic review

Taiwan J Obstet Gynecol. 2020 Mar;59(2):173-182. doi: 10.1016/j.tjog.2020.01.002.

Abstract

Due to the morbidity and mortality of mothers and fetuses developed by preeclampsia, preventive approaches have always been taken into account in high risk individuals. Systematic review studies contribute to make a better decision about the results of such studies. Accordingly, this study strived to systematically study the factors effective in the prevention of preeclampsia. The MEDLINE, ISI Web of Science, PubMed, Scopus, Google Scholar, and Proquest databases were systematically reviewed between January 2000 and May 2019. The quality of the studies was analyzed using the CONSORT checklist. A study was conducted on 29 quality interventional studies; 28 of which were RCT type, and on various factors such as anticoagulants (heparin, enoxaparin, Dalteparin and Nadroparin), aspirin, paravastatin, nitric oxide, yoga, micronutrients Such as l-Arginine, Folic Acid, Vitamin E and C, Phytonutrient, Lycopene and Vitamin D alone or in combination with Calcium. The results of this study showed that low molecular weight heparin, enoxaparin, PETN, yoga, L arginine, folic acid, vitamin D prevented preeclampsia alone or combined with calcium.

Keywords: Preeclampsia; Pregnancy toxemia; Prevention; Prophylaxis.

Publication types

  • Systematic Review

MeSH terms

  • Arginine / therapeutic use
  • Calcium / therapeutic use
  • Drug Therapy, Combination
  • Enoxaparin / therapeutic use
  • Female
  • Folic Acid / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Pentaerythritol Tetranitrate / therapeutic use
  • Pre-Eclampsia / prevention & control*
  • Pregnancy
  • Prenatal Care / methods*
  • Vitamin D / therapeutic use
  • Yoga

Substances

  • Enoxaparin
  • Heparin, Low-Molecular-Weight
  • Pentaerythritol Tetranitrate
  • Vitamin D
  • Folic Acid
  • Arginine
  • Calcium